Immune-related adverse events from contemporary first-line combination therapies in metastatic renal cell carcinoma: Results from the IMDC

被引：0

作者：

Navani, V. ^{[1
]}

Lemelin, A. ^{[1
]}

Powles, T. B. ^{[2
]}

Liow, E. C. H. ^{[3
]}

Wong, S. S. L. ^{[4
]}

Meza, L. A. ^{[5
]}

Ebrahimi, H. ^{[5
]}

Saliby, R. M. ^{[6
]}

Saad, E. ^{[6
]}

Yuasa, T. ^{[7
]}

Wood, L. A. ^{[8
]}

Kollmannsberger, C. K. ^{[9
]}

Graham, J. ^{[10
]}

North, S. ^{[11
]}

Basappa, N. S. ^{[11
]}

Donskov, F. ^{[12
]}

Suarez Rodriguez, C. ^{[13
]}

Lalani, A-K. ^{[14
]}

Choueiri, T. K. ^{[6
]}

Heng, D. Y. C. ^{[1
]}

机构：

[1] Tom Baker Canc Clin, Med Oncol Dept, Calgary, AB, Canada

[2] Barts Hlth NHS Trust, Oncol Dept, St Bartholomews Hosp, London, England

[3] Monash Hlth, Med Oncol, Monash Med Ctr, Clayton, Vic, Australia

[4] Western Hlth, Med Affairs Dept, Sunshine Hosp, St Albans, Vic, Australia

[5] City Hope Comprehens Canc Ctr, Med Oncol, Duarte, CA USA

[6] Dana Farber Canc Inst, Med Oncol Dept, Boston, MA USA

[7] JFCR, Urol, Canc Inst Hosp, Koto Ku, Tokyo, Japan

[8] Dalhousie Univ, Div Med Oncol, Dept Med, Halifax, NS, Canada

[9] BC Canc Agcy Vancouver, Med Oncol Dept, Vancouver, BC, Canada

[10] Univ Manitoba, Med Oncol Dept, Fac Med Internal Med, Winnipeg, MB, Canada

[11] Univ Alberta, Med Oncol Dept, Cross Canc Inst, Edmonton, AB, Canada

[12] Aarhus Univ Hosp, Oncol Dept, Aarhus, Denmark

[13] Vall dHebron Univ Hosp, Oncol Dept, Barcelona, Spain

[14] Hamilton Hlth Sci, Genitourinary Oncol Dept, JCC Juravinski Canc Ctr, Med Oncol Div, Hamilton, ON, Canada

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.09.1123

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1893P

引用

页码：S1018 / S1019

页数：2

共 50 条

[1] Characterizing IMDC prognostic groups in contemporary first-line combination therapies for metastatic renal cell carcinoma (mRCC).
Ernst, Matthew Scott
Navani, Vishal
Wells, J. Connor
Donskov, Frede
Basappa, Naveen S.
Labaki, Chris
Pal, Sumanta K.
Meza, Luis A.
Wood, Lori
Ernst, D. Scott
Szabados, Bernadett
Mckay, Rana R.
Parnis, Francis
Suarez, Cristina
Yuasa, Takeshi
Kapoor, Anil
Alva, Ajjai Shivaram
Bjarnason, Georg A.
Choueiri, Toni K.
Heng, Daniel Yick Chin
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
[2] Predictors of objective response to first-line immuno-oncology combination therapies in metastatic renal cell carcinoma: Results from the international metastatic renal cell database consortium (IMDC).
Navani, Vishal
Ernst, Matthew Scott
Wells, Connor
Yuasa, Takeshi
Takemura, Kosuke
Donskov, Frede
Basappa, Naveen S.
Schmidt, Andrew Lachlan
Pal, Sumanta K.
Meza, Luis A.
Wood, Lori
Ernst, D. Scott
Szabados, Bernadett
McKay, Rana R.
Weickhardt, Andrew James
Suarez, Cristina
Kapoor, Anil
Lee, Jae-Lyun
Choueiri, Toni K.
Heng, Daniel Yick Chin
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
[3] Characterization of patients with metastatic renal cell carcinoma achieving complete response to first-line therapies: Results from the international metastatic renal cell carcinoma database consortium (IMDC)
Takemura, K.
Navani, V.
Ernst, M. S.
Wells, J. C.
Choueiri, T. K.
Meza, L.
Pal, S. K.
Lee, J-L.
Li, H.
Agarwal, N.
Alva, A. S.
Hansen, A. R.
Basappa, N. S.
Szabados, B. E.
Powles, T. B.
Tran, B.
Hocking, C. M.
Beuselinck, B.
Yuasa, T.
Heng, D. Y. C.
ANNALS OF ONCOLOGY, 2022, 33 (07) : S1209 - S1210
[4] First-line therapy for metastatic renal cell carcinoma with pancreatic metastases: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
Roussel, Eduard
Kinget, Lisa
Beuselinck, Benoit
Albersen, Maarten
Wells, Connor
Ernst, Matthew Scott
Donskov, Frede
Schmidt, Andrew Lachlan
Szabados, Bernadett
Pal, Sumanta K.
Meza, Luis A.
Agarwal, Neeraj
Weickhardt, Andrew James
Davis, Ian D.
Alva, Ajjai Shivaram
Wood, Lori
Porta, Camillo
Choueiri, Toni K.
Heng, Daniel Yick Chin
Navani, Vishal
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
[5] First-line (1L) immuno-oncology (10) combination therapies in metastatic renal cell carcinoma (mRCC): Preliminary results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
Dudani, Shaan
Graham, Jeffrey
Wells, Connor
Pal, Sumanta K.
Dizman, Nazli
Donskov, Frede
Bjarnason, Georg A.
Hansen, Aaron Richard
Iafolla, Marco Adelmo James
Vaishampayan, Ulka N.
Porta, Camillo
Beuselinck, Benoit
Yan, Flora
Wood, Lori
Liow, Elizabeth Chien Hern
Kollmannsberger, Christian K.
Yuasa, Takeshi
Zhang, Chiyuan A.
Choueiri, Toni K.
Heng, Daniel Yick Chin
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
[6] First-line sunitinib versus pazopanib in metastatic renal cell carcinoma (mRCC): Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
Morales, Jose Manuel Ruiz
Wells, J. Connor
Donskov, Frede
Bjarnason, Georg A.
Lee, Jae-Lyun
Knox, Jennifer J.
Beuselinck, Benoit
Vaishampayan, Ulka N.
Brugarolas, James
Broom, Reuben James
Bamias, Aristotelis
Yuasa, Takeshi
Srinivas, Sandhya
Ernst, D. Scott
Pezaro, Carmel Jo
Wood, Lori
Kollmannsberger, Christian K.
Rini, Brian I.
Choueiri, Toni K.
Heng, Daniel Yick Chin
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
[7] First-line sunitinib versus pazopanib in metastatic renal cell carcinoma (mRCC): Results from the international metastatic renal cell carcinoma database consortium (IMDC).
Morales, Jose Manuel Ruiz
Swierkowski, Marcin
Wells, Connor
Fraccon, Anna Paola
La Russa, Francesca
Donskov, Frede
Bjarnason, Georg A.
Lee, Jae-Lyun
Sim, Hao-Wen
Beuselinck, Benoit
Wood, Lori
Yuasa, Takeshi
Pezaro, Carmel Jo
Rini, Brian I.
Szczylik, Cezary
Choueiri, Toni K.
Heng, Daniel Yick Chin
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[8] Immune-related adverse events associated with first-line immune checkpoint inhibitors for metastatic renal cell carcinoma: A systematic review and network meta-analysis
Wang, Shan
Lv, Hongwei
Yu, Jing
Chen, Miao
INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 131
[9] The impact of impaired renal function on the effectiveness of first-line immuno-oncology combination therapies in metastatic renal cell carcinoma (mRCC): Results from the international metastatic RCC database consortium (IMDC)
Navani, V.
Ernst, M. S.
Takemura, K.
Pal, S. K.
Powles, T. B.
Donskov, F.
Wells, J. C.
Kollmannsberger, C. K.
Beuselinck, B.
Alva, A. S.
Weickhardt, A. J.
Lalani, A-K.
Ernst, D. S.
Agarwal, N.
Choueiri, T. K.
Heng, D. Y. C.
ANNALS OF ONCOLOGY, 2022, 33 (07) : S1215 - S1216
[10] Management of Immune-Related Adverse Events from Immune-Checkpoint Inhibitors in Advanced or Metastatic Renal Cell Carcinoma
Leucht, Katharina
Ali, Nalyan
Foller, Susan
Grimm, Marc-Oliver
CANCERS, 2022, 14 (18)

← 1 2 3 4 5 →